28 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Teva (TEVA) Q4 Earnings In Line, Stock Up as Sales Stabilize http://www.zacks.com/stock/news/763728/teva-teva-q4-earnings-in-line-stock-up-as-sales-stabilize?cid=CS-ZC-FT-analyst_blog|earnings_article-763728 Feb 13, 2020 - Teva Pharmaceutical (TEVA) earnings match estimates but sales beat. Shares rise 9%.
Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails http://www.zacks.com/stock/news/765605/pharma-stock-roundup-abbv-agn-post-q4-results-another-alzheimers-study-fails?cid=CS-ZC-FT-analyst_blog|stock_roundup-765605 Feb 14, 2020 - AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
Aerie's (AERI) Q4 Loss Wider Than Expected, Revenues Beat http://www.zacks.com/stock/news/777268/aeries-aeri-q4-loss-wider-than-expected-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-777268 Feb 21, 2020 - Aerie (AERI) reports a wider loss in the fourth quarter, while sales surpass expectations.
Biotech ETFs Hit New Highs on Deal Activities http://www.zacks.com/stock/news/663878/biotech-etfs-hit-new-highs-on-deal-activities?cid=CS-ZC-FT-etf_news_and_commentary-663878 Dec 10, 2019 - Following the new deals in the healthcare space, a few biotech ETFs hit new highs.
3 Stocks with Solid Entry Points to Consider for 2020 http://www.zacks.com/stock/news/701275/3-stocks-with-solid-entry-points-to-consider-for-2020?cid=CS-ZC-FT-stocks_in_the_news|investment_ideas-701275 Jan 03, 2020 - Geopolitcal headwinds sent stocks lower on Friday as US officials confirmed that President Trump's airstrike killed Iran's top military commander.
Aerie's (AERI) Application for Roclanda Accepted in Europe http://www.zacks.com/stock/news/700586/aeries-aeri-application-for-roclanda-accepted-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-700586 Jan 03, 2020 - European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.
Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101 http://www.zacks.com/stock/news/704735/editas-edit-focuses-on-developing-eye-candidate-edit-101?cid=CS-ZC-FT-analyst_blog|zer_report_update-704735 Jan 06, 2020 - Editas (EDIT) progresses well on developing its lead candidate EDIT-101 to treat LCA10, a rare genetic illness that causes blindness. Excessive reliance on partners for revenues remains a concern.
3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio http://www.zacks.com/stock/news/718855/3-large-cap-dividend-stocks-to-buy-now-for-your-2020-portfolio?cid=CS-ZC-FT-stocks_in_the_news|investment_ideas-718855 Jan 15, 2020 - Despite all the positivity, investors should think about adding a few large-cap stocks that pay a solid dividend to help anchor their portfolios in 2020...
J&J Seeks Label Expansion for Spravato Nasal Spray in EU http://www.zacks.com/stock/news/720650/jj-seeks-label-expansion-for-spravato-nasal-spray-in-eu?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-720650 Jan 16, 2020 - J&J (JNJ) seeks label expansion for its new nasal spray, Spravato (esketamine), for an expanded patient population in Europe.
Is Allergan (AGN) a Great Stock for Value Investors? http://www.zacks.com/stock/news/720736/is-allergan-agn-a-great-stock-for-value-investors?cid=CS-ZC-FT-analyst_blog|value_stocks-720736 Jan 16, 2020 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.

Pages: 123

<Page 2